KLK8 and early-onset autosomal dominant Alzheimer disease: In this context, several reports have evaluated the cerebral expression of Klk8 at both mRNA and protein levels during Alzheimer’s disease; the impact of Klk8 inhibition on Alzheimer’s disease-related pathology in mice, and primary glial cells has also been tested.